NSAIDs, Increased Risk Of Miscarriage Link Suggested In BMJ Study
This article was originally published in The Tan Sheet
Executive Summary
Use of non-steroidal anti-inflammatory drugs during pregnancy does not appear to increase the risk of adverse birth outcomes but may be associated with an increased risk of miscarriage, Danish researchers report.
You may also be interested in...
Prenatal NSAID Use Significantly Underreported - Study
Easy access to nonsteroidal, anti-inflammatory drugs by pregnant women "should be re-evaluated" in light of findings that in utero exposure to aspirin, ibuprofen and naproxen is significantly higher than indicated by maternal history, Michigan researchers say in the March issue of Pediatrics.
Prenatal NSAID Use Significantly Underreported - Study
Easy access to nonsteroidal, anti-inflammatory drugs by pregnant women "should be re-evaluated" in light of findings that in utero exposure to aspirin, ibuprofen and naproxen is significantly higher than indicated by maternal history, Michigan researchers say in the March issue of Pediatrics.
Prenatal NSAID Use Significantly Underreported - Study
Easy access to nonsteroidal, anti-inflammatory drugs by pregnant women "should be re-evaluated" in light of findings that in utero exposure to aspirin, ibuprofen and naproxen is significantly higher than indicated by maternal history, Michigan researchers say in the March issue of Pediatrics.